Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
3
23%
Ph phase_2
3
23%
Ph phase_4
1
8%
Ph phase_3
5
38%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
5(38.5%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(5)
Other(3)

Detailed Status

Completed5
Not yet recruiting5
unknown3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 23 (23.1%)
Phase 35 (38.5%)
Phase 41 (7.7%)
N/A3 (23.1%)

Trials by Status

completed538%
unknown323%
not_yet_recruiting538%

Recent Activity

0 active trials
Showing 5 of 13
not_yet_recruitingphase_2

Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer

NCT07550205
not_yet_recruitingphase_3

Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas

NCT07505056
not_yet_recruitingnot_applicable

Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer

NCT07050563
not_yet_recruitingnot_applicable

Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia

NCT06747325
not_yet_recruitingphase_2

RCT for the Chinese Medicine in Treating Hypercholesterolemia

NCT06700408
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07550205Phase 2

Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer

Not Yet Recruiting
NCT07505056Phase 3

Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas

Not Yet Recruiting
NCT07050563Not Applicable

Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer

Not Yet Recruiting
NCT06747325Not Applicable

Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia

Not Yet Recruiting
NCT06700408Phase 2

RCT for the Chinese Medicine in Treating Hypercholesterolemia

Not Yet Recruiting
NCT04924881Phase 2

Chinese Medicine for Patients With LCOVID-19 Symptoms

Unknown
NCT02142634Phase 3

Budesonide for Induction of Remission in Incomplete Microscopic Colitis

Completed
NCT02900742Phase 3

Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer

Completed
NCT02889692Phase 3

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Completed
NCT03716388Phase 3

Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

Unknown
NCT01841099Phase 1

Mesalamine in Environmental Enteropathy

Completed
NCT02035644Phase 4

Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)

Unknown
NCT00524693Not Applicable

Montelukast in Acute RSV Bronchiolitis

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13